Belimumab in the treatment of systemic lupus erythematosus: 20 years of basic research, 10 years of clinical practice
Currently, strong evidence has been obtained for the fundamental role of pathological activation of B cells in the pathogenesis of immunoinflammatory (autoimmune) rheumatic diseases (IMRD), and drugs that specifically modulate the function or cause depletion of various subpopulations of B cells and...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Russo |
| Έκδοση: |
IMA PRESS LLC
2021-09-01
|
| Σειρά: | Научно-практическая ревматология |
| Θέματα: | |
| Διαθέσιμο Online: | https://rsp.mediar-press.net/rsp/article/view/3053 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|